pantoprazole has been researched along with Spasmophilia in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quasdorff, M | 1 |
| Mertens, J | 1 |
| Dinter, J | 1 |
| Steffen, HM | 1 |
| Famularo, G | 1 |
| Minisola, G | 1 |
| Bravi, MC | 1 |
| Colucci, P | 1 |
| Gasbarrone, L | 1 |
2 other studies available for pantoprazole and Spasmophilia
| Article | Year |
|---|---|
Recurrent hypomagnesemia with proton-pump inhibitor rechallenge.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Dyspepsia; Female; Humans; Hypocalcemia; Magnesium; | 2011 |
Tetany, hypomagnesemia, and proton-pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biomarkers; Female; Humans; Hypoparathyroidism; Magnesium; | 2012 |